Showing results (211-220 of 271) with videos related to
Sort By:
Pageof 28
Frontiers in Cell and Developmental Biology|August 21, 2023
Role of Kupffer cells in tolerance induction after liver transplantationWeixiong Zheng, Lingxiang Yang, Shiming Jiang, et al.Experimental Cell Research|April 5, 2020
Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarizationXiaoping Zhao, Xiaoying Wang, Yu You, et al.Experimental Cell Research|February 11, 2018
Brg1 promotes liver fibrosis via activation of hepatic stellate cellsHaijie Li, Jingqin Lan, Caishun Han, et al.Cell Death Discovery|April 9, 2025
Development of a breast cancer invasion score to predict tumor aggressiveness and prognosis via PI3K/AKT/mTOR pathway analysisXiujuan Li, Ya Zhang, Jianping Gong, et al.Frontiers in Pharmacology|July 10, 2024
β-blockades and the risk of atrial fibrillation in patients with cardiovascular diseasesXun-Hu Gu, Weichao Li, Heng Li, et al.Molecular Cancer Therapeutics|August 14, 2013
PI3K stimulates DNA synthesis and cell-cycle progression via its p55PIK regulatory subunit interaction with PCNAGuihua Wang, Xiaonian Cao, Senyan Lai, et al.Science in China. Series C, Life Sciences|October 27, 2005
Epstein-Barr virus-encoded latent membrane protein 1 modulates cyclin D1 by c-Jun/Jun B heterodimersXin Song, Yongguang Tao, Liang Zeng, et al.International Journal of Nanomedicine|July 2, 2020
Macrophage Membrane-Coated Nanoparticles Alleviate Hepatic Ischemia-Reperfusion Injury Caused by Orthotopic Liver Transplantation by Neutralizing EndotoxinZhibing Ou, Hua Zhong, Liang Zhang, et al.International Journal of Biological Sciences|July 11, 2022
HTR1D functions as a key target of HOXA10-AS/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via PI3K-AKT signaling pathwayWu Wu, Qujin Li, Zhu Zhu, et al.Molecular Immunology|October 15, 2025
Role of efferocytosis in liver transplantation via hepatic macrophageMinjie Zhao, Xuesong Xu, Haiyang Peng, et al.Pageof 28